TARDBP and amyotrophic lateral sclerosis: The identification of cryptic peptides, products of TDP-43 dysfunction and primarily associated with ALS and frontotemporal dementia (FTD), offers potential not only as early diagnostic markers but also for stratifying patients based on clinical subtypes (Akiyama et al., 2022).